Abstract
Ribosome-targeting antibiotics serve as powerful antimicrobials and as tools for studying the ribosome, the catalytic peptidyl transferase center (PTC) of which is targeted by many drugs. The classic PTC-acting antibiotic chloramphenicol (CHL) and the newest clinically significant linezolid (LZD) were considered indiscriminate inhibitors of protein synthesis that cause ribosome stalling at every codon of every gene being translated. However, recent discoveries have shown that CHL and LZD preferentially arrest translation when the ribosome needs to polymerize particular amino acid sequences. The molecular mechanisms that underlie the context-specific action of ribosome inhibitors are unknown. Here we present high-resolution structures of ribosomal complexes, with or without CHL, carrying specific nascent peptides that support or negate the drug action. Our data suggest that the penultimate residue of the nascent peptide directly modulates antibiotic affinity to the ribosome by either establishing specific interactions with the drug or by obstructing its proper placement in the binding site.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Coordinates and structure factors have been deposited in the RCSB Protein Data Bank with the following accession codes: 7RQA for the T. thermophilus 70S ribosome in complex with protein Y, A-site aminoacyl-tRNA analog ACC-Pmn and P-site peptidyl-tRNA analog ACCA-ITM; 7RQB for the T. thermophilus 70S ribosome in complex with protein Y, A-site aminoacyl-tRNA analog ACC-Pmn and P-site peptidyl-tRNA analog ACCA-IAM; 7RQC for the T. thermophilus 70S ribosome in complex with protein Y, A-site aminoacyl-tRNA analog ACC-Pmn and P-site peptidyl-tRNA analog ACCA-IFM; 7RQD for the T. thermophilus 70S ribosome in complex with protein Y, A-site deacylated tRNA analog CACCA, P-site peptidyl-tRNA analog ACCA-ITM and chloramphenicol; 7RQE for the T. thermophilus 70S ribosome in complex with protein Y, A-site deacylated tRNA analog CACCA, P-site peptidyl-tRNA analog ACCA-IAM and chloramphenicol. All previously published structures that were used in this work for structural comparisons were retrieved from the RCSB Protein Data Bank: PDB entries 6XHW, 6WDD, 1VQN, 1VY7, 6TC3, 5NWY, 6ND5, 3CPW. No sequence data were generated in this study.
References
Blanchard, S. C., Cooperman, B. S. & Wilson, D. N. Probing translation with small-molecule inhibitors. Chem. Biol. 17, 633–645 (2010).
Barnhill, A. E., Brewer, M. T. & Carlson, S. A. Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. Antimicrob. Agents Chemother. 56, 4046–4051 (2012).
Jones, C. N., Miller, C., Tenenbaum, A., Spremulli, L. L. & Saada, A. Antibiotic effects on mitochondrial translation and in patients with mitochondrial translational defects. Mitochondrion 9, 429–437 (2009).
Singh, R., Sripada, L. & Singh, R. Side effects of antibiotics during bacterial infection: mitochondria, the main target in host cell. Mitochondrion 16, 50–54 (2014).
Li, C. H., Cheng, Y. W., Liao, P. L., Yang, Y. T. & Kang, J. J. Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion. Toxicol. Sci. 116, 140–150 (2010).
Cohen, B. H. & Saneto, R. P. Mitochondrial translational inhibitors in the pharmacopeia. Biochim. Biophys. Acta 1819, 1067–1074 (2012).
Syriopoulou, V. P., Harding, A. L., Goldmann, D. A. & Smith, A. L. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob. Agents Chemother. 19, 294–297 (1981).
Dunkle, J. A., Xiong, L., Mankin, A. S. & Cate, J. H. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc. Natl. Acad. Sci. USA 107, 17152–17157 (2010).
Bulkley, D., Innis, C. A., Blaha, G. & Steitz, T. A. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc. Natl. Acad. Sci. USA 107, 17158–17163 (2010).
Svetlov, M. S. et al. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition. RNA 25, 600–606 (2019).
Drainas, D., Kalpaxis, D. L. & Coutsogeorgopoulos, C. Inhibition of ribosomal peptidyltransferase by chloramphenicol. Kinetic studies. Eur. J. Biochem. 164, 53–58 (1987).
Kucan, Z. & Lipmann, F. Differences in chloramphenicol sensitivity of cell-free amino acid polymerization systems. J. Biol. Chem. 239, 516–520 (1964).
Vazquez, D. Antibiotics affecting chloramphenicol uptake by bacteria. Their effect on amino acid incorporation in a cell-free system. Biochim. Biophys. Acta 114, 289–295 (1966).
Cannon, M. The puromycin reaction and its inhibition by chloramphenicol. Eur. J. Biochem. 7, 137–145 (1968).
Rheinberger, H. J. & Nierhaus, K. H. Partial release of AcPhe-Phe-tRNA from ribosomes during poly(U)-dependent poly(Phe) synthesis and the effects of chloramphenicol. Eur. J. Biochem. 193, 643–650 (1990).
Lovett, P. S. Translation attenuation regulation of chloramphenicol resistance in bacteria—a review. Gene 179, 157–162 (1996).
Lovett, P. S. Translational attenuation as the regulator of inducible cat genes. J. Bacteriol. 172, 1–6 (1990).
Marks, J. et al. Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center. Proc. Natl. Acad. Sci. USA 113, 12150–12155 (2016).
Choi, J. et al. Dynamics of the context-specific translation arrest by chloramphenicol and linezolid. Nat. Chem. Biol. 16, 310–317 (2020).
Orelle, C. et al. Tools for characterizing bacterial protein synthesis inhibitors. Antimicrob. Agents Chemother. 57, 5994–6004 (2013).
Moroder, H. et al. Non-hydrolyzable RNA-peptide conjugates: a powerful advance in the synthesis of mimics for 3′-peptidyl tRNA termini. Angew. Chem. Int. Ed. 48, 4056–4060 (2009).
Hartz, D., McPheeters, D. S., Traut, R. & Gold, L. Extension inhibition analysis of translation initiation complexes. Methods Enzymol. 164, 419–425 (1988).
Polikanov, Y. S., Steitz, T. A. & Innis, C. A. A proton wire to couple aminoacyl-tRNA accommodation and peptide-bond formation on the ribosome. Nat. Struct. Mol. Biol. 21, 787–793 (2014).
Svetlov, M. S. et al. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Nat. Chem. Biol. 17, 412–420 (2021).
Loveland, A. B., Demo, G. & Korostelev, A. A. Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading. Nature 584, 640–645 (2020).
Herrero Del Valle, A. et al. Ornithine capture by a translating ribosome controls bacterial polyamine synthesis. Nat. Microbiol. 5, 554–561 (2020).
Su, T. et al. The force-sensing peptide VemP employs extreme compaction and secondary structure formation to induce ribosomal stalling. eLife 6, e25642 (2017).
Goto, Y. & Suga, H. Translation initiation with initiator tRNA charged with exotic peptides. J. Am. Chem. Soc. 131, 5040–5041 (2009).
Tereshchenkov, A. G. et al. Binding and action of amino acid analogs of chloramphenicol upon the bacterial ribosome. J. Mol. Biol. 430, 842–852 (2018).
Chen, C. W. et al. Binding and action of triphenylphosphonium analog of chloramphenicol upon the bacterial ribosome. Antibiotics (Basel) 10, 390 (2021).
Nishio, M. The CH/π hydrogen bond in chemistry. Conformation, supramolecules, optical resolution and interactions involving carbohydrates. Phys. Chem. Chem. Phys. 13, 13873–13900 (2011).
Fersht, A. R. The hydrogen bond in molecular recognition. Trends Biochem. Sci. 12, 301–304 (1987).
Becker, A. H., Oh, E., Weissman, J. S., Kramer, G. & Bukau, B. Selective ribosome profiling as a tool for studying the interaction of chaperones and targeting factors with nascent polypeptide chains and ribosomes. Nat. Protoc. 8, 2212–2239 (2013).
Mohammad, F., Woolstenhulme, C. J., Green, R. & Buskirk, A. R. Clarifying the translational pausing landscape in bacteria by ribosome profiling. Cell Rep. 14, 686–694 (2016).
Ippolito, J. A. et al. Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J. Med. Chem. 51, 3353–3356 (2008).
Tsai, K. et al. Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-022-00723-9 (2022).
Vazquez-Laslop, N. & Mankin, A. S. Context-specific action of ribosomal antibiotics. Annu. Rev. Microbiol. 72, 185–207 (2018).
Vazquez-Laslop, N. & Mankin, A. S. How macrolide antibiotics work. Trends Biochem. Sci. 43, 668–684 (2018).
Arenz, S. et al. Drug sensing by the ribosome induces translational arrest via active site perturbation. Mol. Cell 56, 446–452 (2014).
Arenz, S. et al. A combined cryo-EM and molecular dynamics approach reveals the mechanism of ErmBL-mediated translation arrest. Nat. Commun. 7, 12026 (2016).
Beckert, B. et al. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics. Nat. Commun. 12, 4466 (2021).
Hedstrom, L. IMP dehydrogenase: structure, mechanism and inhibition. Chem. Rev. 109, 2903–2928 (2009).
Steger, J. et al. Efficient access to nonhydrolyzable initiator tRNA based on the synthesis of 3′-azido-3′-deoxyadenosine RNA. Angew. Chem. Int. Ed. 49, 7470–7472 (2010).
Steger, J. & Micura, R. Functionalized polystyrene supports for solid-phase synthesis of glycyl-, alanyl- and isoleucyl-RNA conjugates as hydrolysis-resistant mimics of peptidyl-tRNAs. Bioorg. Med. Chem. 19, 5167–5174 (2011).
Geiermann, A. S., Polacek, N. & Micura, R. Native chemical ligation of hydrolysis-resistant 3′-peptidyl-tRNA mimics. J. Am. Chem. Soc. 133, 19068–19071 (2011).
Melnikov, S. V. et al. Mechanistic insights into the slow peptide bond formation with D-amino acids in the ribosomal active site. Nucleic Acids Res. 47, 2089–2100 (2019).
Polikanov, Y. S., Blaha, G. M. & Steitz, T. A. How hibernation factors RMF, HPF and YfiA turn off protein synthesis. Science 336, 915–918 (2012).
Polikanov, Y. S., Melnikov, S. V., Soll, D. & Steitz, T. A. Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly. Nat. Struct. Mol. Biol. 22, 342–344 (2015).
Almutairi, M. M. et al. Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins. Nucleic Acids Res. 45, 9573–9582 (2017).
Mitcheltree, M. J. et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. Nature 599, 507–512 (2021).
Wilson, D. N. et al. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc. Natl. Acad. Sci. USA 105, 13339–13344 (2008).
Monro, R. E. Ribosomal peptidyltransferase: the fragment reaction. Methods Enzymol. 20, 472–481 (1971).
Acknowledgements
We thank J. Thaler (Innsbruck) for synthetic support for the RNA-peptide conjugates. We thank A. Mankin for his critical reading of the manuscript, as well as K. Ratia and M. Svetlov for valuable suggestions. We thank the staff at NE-CAT beamlines 24ID-C and 24ID-E for help with data collection and freezing of the crystals, especially M. Capel, F. Murphy, I. Kourinov, A. Lynch, S. Banerjee, D. Neau, J. Schuermann, N. Sukumar, J. Withrow, K. Perry, A. Kaya and C. Salbego. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30-GM124165 to NE-CAT). The Eiger 16M detector on the 24ID-E beamline is funded by an NIH-ORIP HEI grant (S10-OD021527 to NE-CAT). This research has used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. This work was supported by the National Institutes of Health (R01-GM132302 to Y.S.P.), the National Science Foundation (MCB-1951405 to N.V.-L.), Illinois State startup funds (Y.S.P.) and Austrian Science Fund FWF (P31691 and F8011 to R.M.).
Author information
Authors and Affiliations
Contributions
L.F. and R.M. synthesized short tripeptidyl-tRNA mimics. D.K. and N.V.-L. performed the toe-printing analysis. E.A.S. and Y.S.P. designed and performed X-ray crystallography experiments. R.M., N.V.-L. and Y.S.P. supervised the experiments. All authors interpreted the results. E.A.S., R.M. and Y.S.P. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks Marat Yusupov and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Anke Sparmann, Sara Osman and Carolina Perdigoto were the primary editors on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Chemical synthesis of hydrolysis-resistant tripeptidyl-ACCA conjugates.
(a) Overview of the synthetic pathway. Chemical structure of functionalized solid support 11 (gray sphere represents amino-functionalized polystyrene support (GE Healthcare, Custom Primer SupportTM 200 Amino) used for peptide assembly (Fmoc chemistry) and RNA assembly (2’-O-TOM chemistry), followed by deprotection and purification using anion-exchange chromatography; DMT = 4,4’-dimethoxytrityl, Fmoc = N-(9-fluorenyl)methoxy-carbonyl, TOM [(triisopropylsilyl)oxy]methyl, AE HPLC = anion-exchange high-pressure liquid chromatography. (b) Anion-exchange HPLC profiles of purified ACCA-Ile-Ala-Met, ACCA-Ile-Thr-Met, and ACCA-Ile-Phe-Met conjugates (left) and LC-ESI mass spectra (right). Anion-exchange chromatography conditions: Dionex DNAPac PA-100 (4×250 mm) column; temperature: Flow rate: 1 mL/min; eluent A: 25 mM Tris-HCl (pH 8.0) and 20 mM NaClO4 in 20% aqueous acetonitrile, eluent B: 25 mM Tris-HCl (pH 8.0) and 0.60 M NaClO4 in 20% aqueous acetonitrile; gradient: 0-35% B in A within 28 min; UV detection at λ = 260 nm.
Extended Data Fig. 2 CHL arrests translation at the MTI/MAI tripeptide sequences.
Ribosome stalling in the presence and absence of CHL revealed by reverse-transcription primer-extension inhibition (toe-printing) assay in a cell-free translation system on wild-type osmC mRNA encoding MTI tripeptide at the N-terminus (lanes 1-2) or its mutant versions encoding either alanine (lanes 3-4) or phenylalanine (lanes 5-6) in the 2nd position. Nucleotide sequences of wild-type osmC mRNA and the corresponding amino acid sequence are shown on the left. White arrowhead marks translation start site. Red and blue arrowheads point to the drug-induced arrest sites within the coding sequences of each of the three used mRNAs. Note that due to the large size of the ribosome, the reverse transcriptase used in the toe-printing assay stops 16 nucleotides downstream of the codon located in the P site. Because osmC mRNA template harbors other downstream alanine codons, CHL also caused ribosome stalling at these downstream sites subsequent to the appearance of Ala, Ser, or Thr residues in the penultimate position of the peptide chain (lanes 2, 4, and 6, blue arrowhead). The results of the toe-printing assay confirmed that the presence of the MTI or MAI tripeptide sequences in the P site of the ribosome results in CHL-dependent stalling, whereas MFI tripeptide sequence is not conducive to ribosome stalling and can serve as a negative control. Experiments were repeated twice independently with similar results.
Extended Data Fig. 3 Superpositioning of the structures of short tRNA analogs with the aminoacylated full-length tRNAs.
(a, b, c) Comparisons of the 70S ribosome structures carrying ACC-Pmn (magenta) in the A site and either ACCA-ITM (a, green), or ACCA-IAM (b, blue), or ACCA-IFM (c, teal) short peptidyl tRNA analogs in the P site with the previous structure of ribosome-bound full-length aminoacyl-tRNAs (PDB entry 6ZHW24). All structures were aligned based on domain V of the 23S rRNA. (d, e, f) Comparisons of the positions of key 23S rRNA nucleotides around the PTC in the same structures. Note that there are no substantial differences in the positions of A- or P-site substrates or the PTC nucleotides.
Extended Data Fig. 4 Comparison of the structure of short MTI-tripeptidyl-tRNA analog with the structures of other ribosome-bound peptidyl-tRNAs.
Superpositioning of Thermus themophilus 70S ribosome structure carrying A-site ACC-Pmn (magenta) and P-site ACCA-ITM tripeptidyl-tRNA analog (green) with the previously reported structures of Escherichia coli 70S ribosome in complex with full-length P-site peptidyl tRNA carrying SpeFL (a) or VemP (b) stalling peptides (PDB entry 6TC326 and 5NWY27, respectively). All structures were aligned based on domain V of the 23S rRNA. Note that the full-length peptidyl-tRNAs feature ester bonds between the ribose of A76 nucleotide of tRNA and the peptide moiety. Also, note that the overall path of the MTI tripeptide in our structure is similar to the trajectories of the SpeFL or VemP stalling peptides in the NPET.
Extended Data Fig. 5 Superposition of the ribosome-bound CHL with the structures of ribosome-bound aa-tRNA and peptidyl-tRNA analogs.
(a) Superposition of CHL with the A-site-bound aa-tRNA analog ACC-Pmn. (b) Superposition of CHL with the P-site-bound peptidyl-tRNA analog ACCA-IFM. The structure of CHL is from PDB entry 6ND510. The structures were aligned based on domain V of the 23S rRNA. Note that the side chains of the incoming amino acid in the A site (a) or the penultimate amino acid of the peptide in the P site (b) clash with CHL in its canonical binding site.
Extended Data Fig. 6 Structure of CHL in complex with the 70S ribosome and MTI-tripeptidyl-tRNA analog.
(a) Overview of the CHL binding site (yellow) in the Thermus thermophilus 70S ribosome in complex with the short tripeptidyl-tRNA analogs viewed as a cross-cut section through the nascent peptide exit tunnel. The 30S subunit is shown in light yellow; the 50S subunit is in light blue; ribosome-bound protein Y is colored in green. (b, c) Close-up views of CHL bound in the PTC, highlighting H-bond interactions (dashed lines) and the intercalation of the nitrobenzyl group into the A-site cleft formed by nucleotides A2451 and C2452 of the 23S rRNA. Note that the side chain of the Thr2 residue of the MTI tripeptide directly interacts with the ribosome-bound CHL.
Extended Data Fig. 7 Short MAI and MFI tripeptidyl-tRNA analogs exhibit opposite effects on CHL binding in vitro.
Binding of radioactively labeled [14C]-CHL to the Thermus thermophilus 50S ribosomal subunits (RS) was measured using fragment reaction assay52 in the presence of the indicated A- and P-site substrates. The synthetic oligonucleotide CACCA (analog of the CCA-end of deacylated tRNA) and ACCA-IAM/IFM compounds (analogs of the CCA-ends of the peptidyl-tRNAs carrying MAI or MFI tripeptide moieties) serving as the A- and P-site substrates, respectively, were the same as those used for the structural studies. Error bars represent standard deviations of the mean of two independent measurements.
Extended Data Fig. 8 In silico modeling of MGI-, MCI-, and MVI-tripeptidyl-tRNA analogs in the presence of CHL.
Using the structure of MAI-tripeptidyl-tRNA analog bound to the ribosome in the presence of CHL as a reference, the second alanine residue was mutated either to glycine (a), cysteine (b), or valine (c) and assessed the modeled structures for sterical clashes.
Supplementary information
Rights and permissions
About this article
Cite this article
Syroegin, E.A., Flemmich, L., Klepacki, D. et al. Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol. Nat Struct Mol Biol 29, 152–161 (2022). https://doi.org/10.1038/s41594-022-00720-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41594-022-00720-y
This article is cited by
-
The SecM arrest peptide traps a pre-peptide bond formation state of the ribosome
Nature Communications (2024)
-
Structural basis of Cfr-mediated antimicrobial resistance and mechanisms to evade it
Nature Chemical Biology (2024)
-
Structural insights into the mechanism of overcoming Erm-mediated resistance by macrolides acting together with hygromycin-A
Nature Communications (2023)
-
Insights into the ribosome function from the structures of non-arrested ribosome–nascent chain complexes
Nature Chemistry (2023)
-
Motif-ation matters
Nature Chemical Biology (2023)